WO1997033552A1
Expired / Lapsed
WO
⏱️ 0.0 years remaining
Water soluble paclitaxel prodrugs
Assignee: Wallace Technologies Inc
•
Filing: 1997-03-11
•
Granted: —
•
Expires: 2017-03-11
Abstract
Abstract Disclosed are water soluble compositions of paclitaxel and docetaxel formed by conjugating the paclitaxel or docetaxel to a water soluble chelator, polyethylene glycol or polymer such as poly (1-glutamic acid) or poly (1-aspartic acid). Also disclosed are methods of using the compositions for treatment of tumors, autoimmune disorders such as rheumatoid arthritis and for prediction of paclitaxel uptake by tumors and radiolabeled DTPA-paclitaxel tumor imaging. Other embodiments include the coating of implantable stents for prevention of restenosis.
Inventors
- 👤 Chun Li
- 👤 Sidney Wallace
- 👤 Dong-Fang Yu
- 👤 David J. Yang
Bibliographic Details
Application Number
—
Jurisdiction
WO
Data Source
google_patents
Last Synchronized
2026-10-23 05:18
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/337; A61K31/365; A61K47/00; A61K47/50; A61K47/51; A61K47/54; A61K47/547; A61K47/56; A61K47/59; A61K47/60; A61K47/62; A61K47/64; A61K47/645; A61K51/00; A61K51/02; A61K51/04; A61K51/0497; A61L; A61L31/00; A61L31/08; A61L31/10; A61L31/14; A61L31/16; A61P; A61P25/00; A61P35/00; A61P37/00; A61P37/02; A61P43/00; A61P9/00; A61P9/08; A61P9/10; A61K2121/00; A61K2123/00; A61L2300/00; A61L2300/40; A61L2300/416; A61L2300/60; A61L2300/606
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.